Cargando…
TSPAN1: A Novel Protein Involved in Head and Neck Squamous Cell Carcinoma Chemoresistance
SIMPLE SUMMARY: Therapy resistance in head and neck squamous cell carcinoma (HNSCC) patients is the main obstacle to achieve more effective treatments that improve survival and quality of life of these patients. Therefore, it is of vital importance to unravel the molecular and cellular mechanisms by...
Autores principales: | Garcia-Mayea, Yoelsis, Mir, Cristina, Carballo, Laia, Castellvi, Josep, Temprana-Salvador, Jordi, Lorente, Juan, Benavente, Sergi, García-Pedrero, Juana M., Allonca, Eva, Rodrigo, Juan P., LLeonart, Matilde E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694336/ https://www.ncbi.nlm.nih.gov/pubmed/33167355 http://dx.doi.org/10.3390/cancers12113269 |
Ejemplares similares
-
SDCBP Modulates Stemness and Chemoresistance in Head and Neck Squamous Cell Carcinoma through Src Activation
por: Mir, Cristina, et al.
Publicado: (2021) -
Transcriptomic and Proteomic Profiles for Elucidating Cisplatin Resistance in Head-and-Neck Squamous Cell Carcinoma
por: Garcia-Mayea, Yoelsis, et al.
Publicado: (2022) -
Targeting Sphingolipids for Cancer Therapy
por: Companioni, Osmel, et al.
Publicado: (2021) -
Autophagy Takes Center Stage as a Possible Cancer Hallmark
por: Alvarez-Meythaler, Jose G., et al.
Publicado: (2020) -
The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021)